Competition Launch to 'Brand' Synthetic Biology Vanilla
By Hispanic Business,
Hispanic Business
| 11. 14. 2013
ETC Group and Friends of the Earth are launching a public design and branding competition to shine a spotlight on synthetic biology (extreme genetic engineering) in our food. Use your creativity to help us expose the very un-natural new ingredient coming to a confection near you, and what it means for vanilla farmers.
More information and entry form at http://www.etcgroup.org/vanilla-competition
As early as next year, a new ingredient straight out of a petri dish could enter our favorite foods - from ice cream to apple pie. It's a 'vanilla-like' flavour (http://www.etcgroup.org/content/case-study-vanilla) produced via a new extreme genetic engineering technology called 'synthetic biology (http://www.etcgroup.org/issues/synthetic-biology).' No government anywhere in the world has taken steps to assess or regulate this technology, yet its imminent arrival on the commercial market may threaten the livelihoods of hundreds of thousands of tropical vanilla farmers and their families in countries such as Madagascar and Mexico.
This new vanilla flavor exists nowhere in nature, but the companies behind it are confident it deserves a 'natural flavor' label. ETC Group (http://www.etcgroup.org/) and Friends...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...